UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y
Number of items: 256.

A

Abi-Rached, L; Jobin, MJ; Kulkarni, S; McWhinnie, A; Dalva, K; Gragert, L; Babrzadeh, F; ... Parham, P; + view all (2011) The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans. SCIENCE , 334 (6052) pp. 89-94. 10.1126/science.1209202.

Adam, J; Hatipoglu, E; O'Flaherty, L; Ternette, N; Sahgal, N; Lockstone, H; Baban, D; ... Pollard, PJ; + view all (2011) Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling. CANCER CELL , 20 (4) 524 - 537. 10.1016/j.ccr.2011.09.006.

Aitchison, KL; Rahim, AA; Hughes, DA; Kinnon, C; Waddington, SN; Howe, SJ; (2011) Lentiviral vectors for gene therapy of Type I Gaucher Disease. HUM GENE THER , 22 (10) A44 - A44.

Albanyan, AA; Albanyan, A; Curry, B; Dragovic, R; Gardiner, C; Biggerstaff, J; Murphy, M; (2011) Measurement of procoagulant microvesicles generated within ageing platelet concentrates. In: (pp. pp. 62-63). WILEY-BLACKWELL

Aleman, MM; Gardiner, C; Harrison, P; Wolberg, AS; (2011) Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. Journal of Thrombosis and Haemostasis , 9 (11) pp. 2251-2261. 10.1111/j.1538-7836.2011.04488.x. Green open access
file

Allay, JA; Sleep, S; Long, S; Tillman, DM; Clark, R; Carney, G; Fagone, P; ... Gray, JT; + view all (2011) Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial. HUM GENE THER , 22 (5) 595 - 604. 10.1089/hum.2010.202.

Allen, CG; Hills, RK; Evans, CM; Lamb, K; Sellar, R; Moorman, AV; Sale, M; ... Gale, RE; + view all (2011) Mutations in a Large Cohort of Young Adult Patients with Core Binding Factor Acute Myeloid Leukemia: Impact on Outcome and the Selection of Patients for Alternative Treatment Including Transplantation in First Complete Remission. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 193). AMER SOC HEMATOLOGY

Alnabhan, R; Madrigal, JA; Saudemont, A; (2011) Activation of cord blood natural killer cells. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 186). WILEY-BLACKWELL

Alvarez, RA; Thorborn, G; Reading, JL; Reddy, S; Vyakarnam, A; (2011) WFDC1 expression identifies memory CD4 T- lymphocytes rendered vulnerable to cell-cell HIV-1 transfer by promoting intercellular adhesive junctions. Retrovirology , 8 (1) p. 29. 10.1186/1742-4690-8-29.

Alvarez-Erviti, L; Seow, Y; Schapira, AH; Gardiner, C; Sargent, IL; Wood, MJA; Cooper, JM; (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiology of Disease , 42 (3) 360 - 367. 10.1016/j.nbd.2011.01.029. Green open access
file

Amary, MF; Damato, S; Halai, D; Eskandarpour, M; Berisha, F; Bonar, F; McCarthy, S; ... Flanagan, AM; + view all (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. NATURE GENETICS , 43 (12) 1262-U129. 10.1038/ng.994.

Anoop, P; Shaw, BE; Riley, U; Ethell, ME; Taj, M; Lancaster, DL; Atra, A; ... Potter, MN; + view all (2011) Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. HEMATOLOGY , 16 (4) 213 - 220. 10.1179/102453311X13025568941763.

Arce, F; Breckpot, K; Collins, M; Escors, D; (2011) Targeting lentiviral vectors for cancer immunotherapy. Curr Cancer Ther Rev , 7 (4) pp. 248-260. 10.2174/157339411797642605. Green open access
file

Arce, F; Breckpot, K; Stephenson, H; Karwacz, K; Ehrenstein, MR; Collins, M; Escors, D; (2011) Selective ERK Activation Differentiates Mouse and Human Tolerogenic Dendritic Cells, Expands Antigen-Specific Regulatory T Cells, and Suppresses Experimental Inflammatory Arthritis. ARTHRITIS RHEUM-US , 63 (1) 84 - 95. 10.1002/art.30099.

Arce, F; Breckpot, K; Stephenson, H; Karwacz, K; Ehrenstein, MR; Collins, M; Escors, D; (2011) Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis. Arthritis and Rheumatism , 63 (1) pp. 84-95. 10.1002/art.30099.

Ayto, R.M.; (2011) Investigation of the linkage between Gaucher disease and BCell disorders including multiple myeloma. Doctoral thesis , UCL (University College London). Green open access
file

Ayto, RM; Reed, M; Baker, R; Steele, AJ; Wickremasinghe, RG; Mehta, AB; Hughes, DA; (2011) Gaucher derived mono-layers prime myeloma cells for survival against chemo-therapeutic agents. Presented at: 51st Annual Scientific Meeting of the British-Society-for-Haematology, Brighton, ENGLAND.

B

Ball, J; Cohen, H; Knowles, S; (2011) A retrospective audit of fluid balance recording in transfusion associated circulatory overload (TACO) reports analysed by the serious hazards of transfusion 9SHOT) scheme. In: (Proceedings) British Blood Transfusion Society.

Ballingall, KT; Herrmann-Hoesing, L; Robinson, J; Marsh, SGE; Stear, MJ; (2011) A single nomenclature and associated database for alleles at the major histocompatibility complex class II DRB1 locus of sheep. TISSUE ANTIGENS , 77 (6) pp. 546-553. 10.1111/j.1399-0039.2011.01637.x.

Bennett, CL; Fallah-Arani, F; Conlan, T; Trouillet, C; Goold, H; Chorro, L; Flutter, B; ... Chakraverty, R; + view all (2011) Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. Blood , 117 (26) 7063 - 7069. 10.1182/blood-2011-01-329185.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; Buckley, S; ... Nathwani, A; + view all (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45 - A45.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; Buckley, S; ... Nathwani, A; + view all (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45-A45.

Bochtler, W; Maiers, M; Bakker, JNA; Oudshoorn, M; Marsh, SGE; Baier, D; Hurley, CK; (2011) World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant , 46 (3) pp. 338-343. 10.1038/bmt.2010.132.

Bolli, N; Payne, EM; Rhodes, J; Gjini, E; Johnston, AB; Guo, F; Lee, J-S; ... Look, AT; + view all (2011) cpsf1 is required for definitive HSC survival in zebrafish. Blood , 117 (15) pp. 3996-4007. 10.1182/blood-2010-08-304030.

Boo, M; van Walraven, SM; Chapman, J; Lindberg, B; Schmidt, AH; Shaw, BE; Switzer, GE; ... World Marrow Donor Assoc, ; + view all (2011) Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. BLOOD , 117 (1) 21 - 25. 10.1182/blood-2010-07-298430.

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? Nephrol Dial Transplant , 26 (2) pp. 742-744. 10.1093/ndt/gfq644.

Briesemeister, D; Sommermeyer, D; Loddenkemper, C; Loew, R; Uckert, W; Blankenstein, T; Kammertoens, T; (2011) Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis. INT J CANCER , 128 (2) 371 - 378. 10.1002/ijc.25350.

C

Calcagnino, M; O'Mahony, C; Coats, C; Cardona, M; Garcia, A; Janagarajan, K; Mehta, A; ... Elliott, PM; + view all (2011) Exercise-Induced Left Ventricular Outflow Tract Obstruction in Symptomatic Patients With Anderson-Fabry Disease. J AM COLL CARDIOL , 58 (1) 88 - 89. 10.1016/j.jacc.2011.03.020.

Calleja-Agius, J; Muttukrishna, S; Pizzey, AR; Jauniaux, E; (2011) Pro- and antiinflammatory cytokines in threatened miscarriages. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , 205 (1) 10.1016/j.ajog.2011.02.051.

Cappellini, MD; Bejaoui, M; Agaoglu, L; Canatan, D; Capra, M; Cohen, A; Drelichman, G; ... Aydinok, Y; + view all (2011) Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. BLOOD , 118 (4) 884 - 893. 10.1182/blood-2010-11-316646.

Carlin, LM; Evans, R; Milewicz, H; Fernandes, L; Matthews, DR; Perani, M; Levitt, J; ... Ng, T; + view all (2011) A Targeted siRNA Screen Identifies Regulators of Cdc42 Activity at the Natural Killer Cell Immunological Synapse. SCIENCE SIGNALING , 4 (201) 10.1126/scisignal.2001729.

Carpenter, J-P; He, T; Kirk, P; Roughton, M; Anderson, LJ; de Noronha, SV; Sheppard, MN; ... Pennell, DJ; + view all (2011) On T2*Magnetic Resonance and Cardiac Iron. CIRCULATION , 123 (14) pp. 1519-1528. 10.1161/CIRCULATIONAHA.110.007641.

Carrera-Marin, AL; Romay-Penabad, Z; Machin, S; Cohen, H; Weston-Davies, W; Pierangeli, SS; (2011) C5 Inhibitor rEV576 Ameliorates In Vivo Effects of Antiphospholipid Antibodies. In: (Proceedings) 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S5-S5). WILEY-BLACKWELL

Carrera-Marin, AL; Romay-Penabad, Z; Weston-Davis, W; Machin, S; Cohen, H; Pierangeli, SS; (2011) C5 inhibitor rEV576 ameliorates in vivo effects of antiphospholipid antibodies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 290.

Casper, CJ; Warner, TT; Taanman, JW; Nathwani, AC; (2011) Generation of iPS-derived dopaminergic neurons as an in-vitro model of Rapid-Onset Dystonia Parkinsonism. HUMAN GENE THERAPY , 22 (10) A42 - A43.

Catlin, SN; Busque, L; Gale, RE; Guttorp, P; Abkowitz, JL; (2011) The replication rate of human hematopoietic stem cells in vivo. BLOOD , 117 (17) 4460 - 4466. 10.1182/blood-2010-08-303537.

Chakraverty, R; Mackinnon, S; (2011) Allogeneic Transplantation for Lymphoma. J CLIN ONCOL , 29 (14) 1855 - 1863. 10.1200/JCO.2010.32.8419.

Chapman, CE; Stainsby, D; Jones, H; Love, E; Massey, E; Win, N; Navarrete, C; ... Williamson, L; + view all (2011) Erratum: Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma (Transfusion (2009) 49 (440-452)). Transfusion , 51 (12) 2746-. 10.1111/j.1537-2995.2011.03496.x.

Cire, S; Collins, MK; Buchholz, C; Galy, A; (2011) In vivo immunization against male antigens and GFP, with lentiviruses targeted to MHC class II positive cells. HUMAN GENE THERAPY , 22 (10) A69-A69.

Cire, S; Collins, MK; Buchholz, CJ; Galy, A; (2011) An experimental model set-up to study MHC class II targeted gene transfer in antigen-presenting-cells. In: (Proceedings) 10th Annual Congress of the French-Society-of-Cell-and-Gene-Therapy (SFTCG). (pp. A24-A25). MARY ANN LIEBERT INC

Cohen, H; (2011) Current best practice in oral anticoagulation. In: (Proceedings) Sysmex user symposium.

Cohen, H; (2011) Heritable thrombotic risk factors: influence on antiphospholipid syndrome pregnancy outcomes and treatment in pregnancy. Presented at: VIII European Forum on antiphospholipid antibodies, Padua.

Cohen, H; (2011) Heritable thrombotic risk factors: influence on antiphospholipid syndrome pregnancy outcomes and treatment in pregnancy. Presented at: VIII European Forum on antiphospholipid antibodies, Padua.

Cohen, H; (2011) New oral anticoagulants in antiphospholipid syndrome: the RAPS trisl. [Lecture]. Presented at: APS ACTION 2nd annual summit, Chicago.

Cohen, H; (2011) Placental vascular mediated late obstetric morbidity: management and outcomes. [Lecture]. Presented at: British society for haematology obstetric subgroup, Leicester.

Cohen, H; (2011) SHOT 2010 and improving patient safety through interventions based on SHOT data. [Lecture]. Presented at: SHOT annual symposium, London.

Confer, DL; Shaw, BE; Pamphilon, DH; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. Bone Marrow Transplantation , 46 (11) pp. 1409-1412. 10.1038/bmt.2010.323.

Confer, DL; Shaw, BE; Pamphilon, DH; Clinical Working Grp WMDA, ; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. BONE MARROW TRANSPL , 46 (11) 1409 - 1412. 10.1038/bmt.2010.323.

D

David, AL; McIntosh, J; Peebles, DM; Cook, T; Waddington, S; Weisz, B; Wigley, V; ... Nathwani, AC; + view all (2011) Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep. HUM GENE THER , 22 (4) 419 - 426. 10.1089/hum.2010.007.

Davies, T; Poles, D; Watt, A; Ball, J; Mistry, H; Knowles, S; Cohen, H; (2011) SHOT participation and benchmarking data 2010. In: (Proceedings) British Blood Transfusion Society.

Deegan, PB; Pavlova, E; Tindall, J; Stein, PE; Bearcroft, P; Mehta, A; Hughes, D; ... Cox, TM; + view all (2011) Osseous Manifestations of Adult Gaucher Disease in the Era of Enzyme Replacement Therapy. MEDICINE , 90 (1) pp. 52-60. 10.1097/MD.0b013e3182057be4.

Della Peruta, M; Binny, C; Nathwani, D; Chokshi, S; McIntosh, J; Rosales, C; Davidoff, AM; ... Nathwani, AC; + view all (2011) The development of a tumour-selective recombinant adeno-associated virus vector to target hepatocellular carcinoma. HUMAN GENE THERAPY , 22 (10) A113 - A113.

Denbo, JW; Williams, RF; Orr, WS; Sims, TL; Ng, CY; Zhou, JF; Spence, Y; ... Davidoff, AM; + view all (2011) Continuous local delivery of interferon-beta stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model. SURGERY , 150 (3) 497 - 504. 10.1016/j.surg.2011.07.044.

Deugnier, Y; Turlin, B; Ropert, M; Cappellini, MD; Porter, JB; Giannone, V; Zhang, Y; ... Brissot, P; + view all (2011) Improvement in Liver Pathology of Patients With beta-Thalassemia Treated With Deferasirox for at Least 3 Years. GASTROENTEROLOGY , 141 (4) 1202-U618. 10.1053/j.gastro.2011.06.065.

Donaldson, J; Khan, WS; Tailor, H; Hughes, DA; Mehta, AB; Maruthainar, N; (2011) Gaucher disease: outcome following total hip replacements and effect of enzyme replacement therapy in a cohort of UK patients. HIP INTERNATIONAL , 21 (6) pp. 665-671. 10.5301/HIP.2011.8826.

Dragovic, RA; Gardiner, C; Brooks, AS; Tannetta, DS; Ferguson, DJP; Hole, P; Carr, B; ... Sargent, IL; + view all (2011) Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine: Nanotechnology, Biology and Medicine , 7 (6) pp. 780-788. 10.1016/j.nano.2011.04.003. Green open access
file

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 2). WILEY-BLACKWELL

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (pp. p. 2).

Drebes, AB; Khalil, A; O'Brien, P; Cohen, H; (2011) Late obstetric morbidity in women with and without inherited or acquired thrombophilia: management and outcomes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 631.

Duarte, RF; Shaw, BE; Marin, P; Kottaridis, P; Ortiz, M; Morante, C; Delgado, J; ... Russell, NH; + view all (2011) Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. BONE MARROW TRANSPL , 46 (1) 52 - 58. 10.1038/bmt.2010.54.

de Groot, NG; Otting, N; Robinson, J; Marsh, SGE; Bontrop, RE; (2011) THE IPD-MHC NHP DATABASE: NEW NOMENCLATURE FOR THE NON-HUMAN PRIMATE MHC ALLELES. In: (Proceedings) 37th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. S100-S100). ELSEVIER SCIENCE INC

E

El-Sharkawi, D; Ramsay, A; Cwynarski, K; Hughes, D; Prentice, A; Davies, N; Goode, A; ... McNamara, C; + view all (2011) Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques. LEUKEMIA LYMPHOMA , 52 (11) 2130 - 2134. 10.3109/10428194.2011.589546.

Elliott, P; Baker, R; Pasquale, F; Quarta, G; Ebrahim, H; Mehta, AB; Hughes, DA; (2011) Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey. HEART , 97 (23) 1957 - 1960. 10.1136/heartjnl-2011-300364.

Escors, D; Bricogne, C; Arce, F; Kochan, G; Karwacz, K; (2011) On the Mechanism of T cell receptor down-modulation and its physiological significance. J Biosci Med , 1 (1)

Evans, P; Cindrova-Davies, T; Muttukrishna, S; Burton, GJ; Porter, J; Jauniaux, E; (2011) Hepcidin and iron species distribution inside the first-trimester human gestational sac. MOL HUM REPROD , 17 (4) 227 - 232. 10.1093/molehr/gaq101.

F

Farren, TW; Liu, F; Macey, MG; Jenner, M; Prentice, A; Nathwani, A; Agrawal, SG; (2011) CD160: a novel approach to minimal residual disease (MRD) assessment in chronic lymphocytic leukaemia (CLL). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 72). WILEY-BLACKWELL

Fernandes, E; Goold, HD; Kissenpfennig, A; Malissen, B; Dyson, J; Bennett, CL; (2011) The Role of Direct Presentation by Donor Dendritic Cells in Rejection of Minor Histocompatibility Antigen-Mismatched Skin and Hematopoietic Cell Grafts. Transplantation , 91 (2) 154 - 160. 10.1097/TP.0b013e318201ac27. Green open access
file

Ferrer, IR; Araki, K; Ford, ML; (2011) Paradoxical aspects of rapamycin immunobiology in transplantation. Am J Transplant , 11 (4) pp. 654-659. 10.1111/j.1600-6143.2011.03473.x.

Ferrer, IR; Wagener, ME; Song, M; Kirk, AD; Larsen, CP; Ford, ML; (2011) Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. Proc Natl Acad Sci U S A , 108 (51) pp. 20701-20706. 10.1073/pnas.1105500108.

Fielding, AK; (2011) Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA , 25 (6) 1255-+. 10.1016/j.hoc.2011.09.008.

Fielding, AK; (2011) Current Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM pp. 231-237. 10.1182/asheducation-2011.1.231.

Fielding, AK; (2011) Philadelphia-Positive Acute Lymphoblastic Leukemia-Is Bone Marrow Transplant Still Necessary? BIOL BLOOD MARROW TR , 17 (1) S84 - S88. 10.1016/j.bbmt.2010.11.023.

Flutter, B; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced Co-Stimulation and Co-Inhibitory Blockade Synergize to Enhance the Functions of Exhausted CTL. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 833-834). AMER SOC HEMATOLOGY

Flutter, B; Velica, P; Chakraverty, R; (2011) Memory lapses in graft-versus-host disease. EUR J IMMUNOL , 41 (9) 2530 - 2534. 10.1002/eji.201141946.

Flutter, BR; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced co-stimulation and co-inhibitory blockade synergise to enhance the functions of exhausted CTL. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 38). WILEY-BLACKWELL

Foley, JH; Cook, PF; Nesheim, ME; (2011) Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites. Journal of Biological Chemistry , 286 (22) pp. 19280-19286. 10.1074/jbc.m110.215061.

G

Gal, A; Hughes, DA; Winchester, B; (2011) Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group. J INHERIT METAB DIS , 34 (2) 509 - 514. 10.1007/s10545-010-9261-9.

Gardiner, C; Tannetta, DS; Harrison, P; Redman, CWG; Sargent, IL; (2011) Increased levels of tissue factor activity on syncytiotrophoblast microvesicles released into the maternal circulation during pre-eclampsia. In: (pp. p. 169). WILEY-BLACKWELL

Gardiner, C; Tannetta, DS; Simms, CA; Harrison, P; Redman, CWG; Sargent, IL; (2011) Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PLoS One , 6 (10) , Article e26313. 10.1371/journal.pone.0026313. Green open access
file

Goold, HD; Escors, D; Conlan, TJ; Chakraverty, R; Bennett, CL; (2011) Conventional Dendritic Cells Are Required for the Activation of Helper-Dependent CD8 T Cell Responses to a Model Antigen After Cutaneous Vaccination with Lentiviral Vectors. Journal of Immunology , 186 (8) 4565 - 4572. 10.4049/jimmunol.1002529.

Grabher, C; Payne, EM; Johnston, AB; Bolli, N; Lechman, E; Dick, JE; Kanki, JP; (2011) Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. LEUKEMIA , 25 (3) pp. 506-514. 10.1038/leu.2010.280.

Green, CL; Evans, CM; Zhao, L; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2011) The prognostic significance of IDH2 mutations in AML depends on the location of the mutation. BLOOD , 118 (2) 409 - 412. 10.1182/blood-2010-12-322479.

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 3). WILEY-BLACKWELL

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (pp. p. 3).

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of an automated thrombin generation assay which is sensitive to defects of protein C pathway. In: J THROMB HAEMOST. (pp. 154 - 154). WILEY-BLACKWELL

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The effect of total hip and knee replacement surgery and dabigatran on thrombin generation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 658.

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The impact of dabigatran on thrombin generation and other haemostatic markers after orthopaedic surgery. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 76). WILEY-BLACKWELL

Green, L.; (2011) The impact of total hip/knee replacement surgery and chemical prophylaxis on thrombin generation. Doctoral thesis , UCL (University College London).

Gutierrez, A; Grebliunaite, R; Feng, H; Kozakewich, E; Zhu, S; Guo, F; Payne, E; ... Look, AT; + view all (2011) Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. JOURNAL OF EXPERIMENTAL MEDICINE , 208 (8) pp. 1595-1603. 10.1084/jem.20101691.

H

Harrison, P; Mackie, I; Mumford, A; Briggs, C; Liesner, R; Winter, M; Machin, S; (2011) Guidelines for the laboratory investigation of heritable disorders of platelet function. BRIT J HAEMATOL , 155 (1) 30 - 44. 10.1111/j.1365-2141.2011.08793.x.

Hayee, B; Antonopoulos, A; Murphy, EJ; Rahman, FZ; Sewell, G; Smith, BN; McCartney, S; ... Segal, AW; + view all (2011) G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. GLYCOBIOLOGY , 21 (7) 914 - 924. 10.1093/glycob/cwr023.

Hernandez, D; Ruban, L; Mason, C; (2011) Feeder-Free Culture of Human Embryonic Stem Cells for Scalable Expansion in a Reproducible Manner. STEM CELLS DEV , 20 (6) 1089 - 1098. 10.1089/scd.2009.0507.

Herzog, RW; Davidoff, AM; Markusic, DM; Nathwani, AC; (2011) AAV Vector Biology in Primates: Finding the Missing Link? MOL THER , 19 (11) 1923 - 1924. 10.1038/mt.2011.218.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; Oscier, DG; ... Pocock, CF; + view all (2011) RITUXIMAB PLUS CHLORAMBUCIL (R-CHLORAMBUCIL) AS FIRST-LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): FINAL ANALYSIS OF AN OPEN-LABEL PHASE II STUDY. In: ANNALS OF ONCOLOGY. (pp. 123 - 123). OXFORD UNIV PRESS

Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; Oscier, DG; ... Pocock, CFE; + view all (2011) Final response assessment of the CLL208 trial: an open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukaemia (CLL). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 21). WILEY-BLACKWELL

Hiwarkar, P; Shaw, BE; Tredger, JM; Brown, NW; Kulkarni, S; Saso, R; Evans, S; ... Potter, MN; + view all (2011) Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. CLIN TRANSPLANT , 25 (2) 222 - 227. 10.1111/j.1399-0012.2010.01226.x.

Hollenbach, JA; Mack, SJ; Gourraud, P-A; Single, RM; Maiers, M; Middleton, D; Thomson, G; ... Varney, MD; + view all (2011) A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. TISSUE ANTIGENS , 78 (5) pp. 333-344. 10.1111/j.1399-0039.2011.01777.x.

Hughes, D; (2011) Gaucher disease: hematologic and oncologic implications. Clin Adv Hematol Oncol , 9 (10) pp. 771-772.

Hughes, D; Barba-Romero, MA; Hollak, CE; Giugliani, R; Deegan, PB; (2011) DELAYED MENARCHE AND EARLY MENOPAUSE IN FEMALES WITH FABRY DISEASE. Presented at: UNSPECIFIED.

Hughes, DA; Al-Sayed, M; Belmatoug, N; Bodamer, O; Bottcher, T; Cappellini, M; Cohen, IJ; ... Weinreb, N; + view all (2011) Early access experience with VPRIV (R): Recommendations for 'core data' collection. BLOOD CELL MOL DIS , 47 (2) 140 - 142. 10.1016/j.bcmd.2010.10.015.

Hughes, DA; Romero, MAB; Hollak, CEM; Giugliani, R; Deegan, PB; FOS Investigators, ; (2011) Response of women with Fabry disease to enzyme replacement therapy: Comparison with men, using data from FOS-the Fabry Outcome Survey. MOL GENET METAB , 103 (3) 207 - 214. 10.1016/j.ymgme.2011.03.022.

J

JD, O; Adcock, DM; Ambrose Bush, T; de Moerloose, P; Gardiner, C; Ginyard, M; McMahan, CA; ... others, ; + view all (2011) Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Clinical and Laboratory Standards Institute

K

Kallinikou, K; Anjos-Afonso, F; Blundell, MP; Ings, SJ; Kassen, D; Thrasher, AJ; Linch, DC; ... Yong, K; + view all (2011) CD26 Inhibition Can Aid the Homing of Cytokine Activated Mobilized Peripheral Blood (MPB)CD34+Cells to the Bone Marrow (BM) but a Ligand Dependent Attachment Defect Prevents Their Long Term Retention and Subsequent Engraftment. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 68). AMER SOC HEMATOLOGY

Kanga, U; McWhinnie, A; Mourya, MK; Sharma, R; Shaw, BE; Madrigal, A; Mehra, NK; (2011) HLA-DPB1 POLYMORPHISM IN NORTH INDIAN POPULATION. In: (Proceedings) 37th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. S137-S137). ELSEVIER SCIENCE INC

Kanga, U; McWhinnie, AJ; Mourya, M; Shaw, BE; Madrigal, JA; Mehra, NK; (2011) A novel HLA-DPB1 allele, DPB1*125:01, identified by sequence-based typing in an Indian individual. TISSUE ANTIGENS , 77 (1) 85 - 87. 10.1111/j.1399-0039.2010.01562.x.

Karwacz, K; Bricogne, C; MacDonald, D; Arce, F; Bennett, CL; Collins, M; Escors, D; (2011) PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8(+) T cells. EMBO Molecular Medicine , 3 (10) 581 - 592. 10.1002/emmm.201100165. Green open access
file

Kasperavičiute, D; Catarino, CB; Chinthapalli, K; Clayton, LMS; Thom, M; Martinian, L; Cohen, H; ... Sisodiya, SM; + view all (2011) Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions. PLoS ONE , 6 (8) , Article e23182. 10.1371/journal.pone.0023182. Green open access
file

Kassen, D; Rabin, N; Lath, D; Croucher, P; Yong, K; (2011) Deregulation of the bone marrow stromal compartment occurs early in multiple myeloma and precedes osteolytic bone disease. In: BONE. (pp. S253 - S254). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, PI; Yong, K; (2011) Mechanisms of osteoblast supression in multiple myeolma. In: BONE. (pp. S37 - S37). ELSEVIER SCIENCE INC

Katodritou, E; Terpos, E; North, J; Kottaridis, P; Verrou, E; Gastari, V; Chadjiaggelidou, C; ... Lowdell, MW; + view all (2011) Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells. AMERICAN JOURNAL OF HEMATOLOGY , 86 (12) pp. 967-973. 10.1002/ajh.22163.

Kautz-Neu, K; Noordegraaf, M; Dinges, S; Bennett, CL; John, D; Clausen, BE; von Stebut, E; (2011) Langerhans cells are negative regulators of the anti-Leishmania response. JOURNAL OF EXPERIMENTAL MEDICINE , 208 (5) pp. 885-891. 10.1084/jem.20102318.

Kepp, O; Galluzzi, L; Martins, I; Schlemmer, F; Adjemian, S; Michaud, M; Sukkurwala, AQ; ... Kroemer, G; + view all (2011) Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev , 30 (1) pp. 61-69. 10.1007/s10555-011-9273-4.

Khwaja, A; (2011) PI3K as a Target for Therapy in Haematological Malignancies. CURR TOP MICROBIOL , 347 169 - 188. 10.1007/82_2010_71.

Khwaja, A; Quinn, J; Yong, KL; (2011) The myeloma bone marrow environment and survival signaling. In: Myeloma: Pathology, Diagnosis, and Treatment. (pp. 64-83).

King, RJ; Confer, DL; Greinix, HT; Halter, J; Horowitz, M; Schmidt, AH; Costeas, P; ... Ethics and Clinical Working Groups of World Marrow Donor Associa, ; + view all (2011) Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant , 46 (1) pp. 10-13. 10.1038/bmt.2010.37.

Kistler, AD; Siwy, J; Breunig, F; Jeevaratnam, P; Scherl, A; Mullen, W; Warnock, DG; ... Serra, AL; + view all (2011) A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy. PLOS ONE , 6 (6) , Article e20534. 10.1371/journal.pone.0020534. Green open access
file

Knowles, S; Cohen, H; (2011) The 2010 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Kothari, J; Ljubic, A; Peggs, KS; Thomson, K; Morris, E; Virchis, AE; Lambert, J; ... Ardeshna, KM; + view all (2011) Autologous Stem Cell Transplantation Using BEAM Conditioning Is Highly Effective in Patients with Follicular Lymphoma Regardless of Prior Rituximab Exposure. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 886). AMER SOC HEMATOLOGY

Kottaridis, P; Tsirogianni, M; North, J; Marden, C; Mackinnon, S; Lowdell, MW; (2011) Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). (pp. p. 431). AMER SOC HEMATOLOGY

Kroemer, G; Adjemian, S; Michaud, M; Martins, I; Kepp, O; Sukkurwala, AQ; Menger, L; ... Zitvogel, L; + view all (2011) [Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]. Bull Mem Acad R Med Belg , 166 (3-4) pp. 130-138.

L

Lambert, J.R.; (2011) Investigations into the molecular pathogenesis of essential thrombocythaemia. Doctoral thesis , UCL (University College London). Green open access
file

Lambrianides, A; Turner-Stokes, T; Pericleous, C; Ehsanullah, J; Papadimitraki, E; Poulton, K; Ioannou, Y; ... Giles, I; + view all (2011) Interactions of Human Monoclonal and Polyclonal Antiphospholipid Antibodies With Serine Proteases Involved in Hemostasis. ARTHRITIS AND RHEUMATISM , 63 (11) pp. 3512-3521. 10.1002/art.30525.

Lawley, S; Cohen, H; Pavord, S; Fitzmaurice, D; (2011) Dragons den on oral anticoagulants for atrial fibrillation. Presented at: British society for haematology annual scientific meeting, Brighton.

Lawrie, AS; Canciani, MT; Iseppi, J; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) High throughput detection of von Willebrand's disease using a new coagulation analyser. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 672.

Lawrie, AS; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) Evaluation of an automated platelet-based assay of ristocetin cofactor activity. HAEMOPHILIA , 17 (2) 252 - 256. 10.1111/j.1365-2516.2010.02419.x.

Lee, F; Madrigal, A; Shaw, B; Saudemont, A; (2011) Study of the effect of CAMPATH on cord blood and peripheral blood cells. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 184). WILEY-BLACKWELL

Lee, JW; Yoon, S-S; Shen, ZX; Ganser, A; Hsu, H-C; El-Ali, A; Habr, D; ... Porter, JB; + view all (2011) Hematologic Responses in Patients with Aplastic Anemia Treated with Deferasirox: A Post-Hoc Analysis From the EPIC Study. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 591-592). AMER SOC HEMATOLOGY

Lee, L; Aziz, M; Wechalekar, A; Rabin, N; (2011) Coexistent asymptomatic myeloma and hereditary cardiac amyloidosis: an unusual case of heart failure. BRITISH JOURNAL OF HOSPITAL MEDICINE , 72 (11) pp. 650-651. 10.12968/hmed.2011.72.11.630.

Linthorst, GE; Germain, DP; Hollak, CEM; Hughes, D; Rolfs, A; Wanner, C; Mehta, A; (2011) Expert opinion on temporary treatment recommendations for Fabry the disease during the shortage of enzyme replacement therapy (ERT). MOL GENET METAB , 102 (1) 99 - 102. 10.1016/j.ymgme.2010.11.155.

Lotta, LA; Wu, HM; Mackie, IJ; Noris, M; Veyradier, A; Machin, SJ; Remuzzi, G; ... Peyvandi, F; + view all (2011) Residual plasmatic activity of ADAMTS13 in congenital thrombotic thrombocytopenic purpura and its correlation with disease phenotype. J THROMB HAEMOST , 9 26 - 27.

Lotta, LA; Wu, HM; Scully, MA; Noris, M; Veyradier, A; Mackie, IJ; Remuzzi, G; ... Peyvandi, F; + view all (2011) Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 966). AMER SOC HEMATOLOGY

Louis, CU; Savoldo, B; Dotti, G; Pule, M; Yvon, E; Myers, GD; Rossig, C; ... Brenner, MK; + view all (2011) Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. BLOOD , 118 (23) pp. 6050-6056. 10.1182/blood-2011-05-354449.

Lowry, L; Smith, P; Qian, W; Falk, S; Benstead, K; Illidge, T; Linch, D; ... Hoskin, P; + view all (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol , 100 (1) pp. 86-92. 10.1016/j.radonc.2011.05.013.

Luevano, ME; Pedroza-Pacheco, I; Derniame, S; Escobedo-Cousin, MH; Madrigal, JA; Saudemont, A; (2011) Generation of natural killer cells from cord blood stem cells, characterization and application for immunotherapy. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 187). WILEY-BLACKWELL

M

Mackie, I; Eapen, CE; Neil, D; Lawrie, AS; Chitolie, A; Shaw, JC; Elias, E; (2011) Idiopathic Noncirrhotic Intrahepatic Portal Hypertension is Associated with Sustained ADAMTS13 Deficiency. DIGEST DIS SCI , 56 (8) 2456 - 2465. 10.1007/s10620-011-1729-4.

Mackie, IJ; Chitolie, A; Westwood, JP; Lawrie, A; Carr, P; Liesner, R; Cohen, H; (2011) Antibodies against prothrombin/phosphatidyl serine in thrombosis an pregnancy morbidity. In: (Proceedings) VII European Forum on antiphospholipid antibodies.

Mackie, IJ; Langley, K; Chitolie, A; Leisner, R; Scully, M; Machin, S; Peyvandi, F; (2011) Discrepancies between different types of ADAMTS13 assays in patients with thrombotic microangiopathies. J THROMB HAEMOST , 9 210 - 210.

Mackinnon, S; Chakraverty, R; (2011) Families get mobilized to treat AML. BLOOD , 117 (3) 746 - 748. 10.1182/blood-2010-11-315929.

Maggio, A; Filosa, A; Vitrano, A; Aloj, G; Kattamis, A; Ceci, A; Fucharoen, S; ... Gluud, C; + view all (2011) Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials. BLOOD CELLS MOLECULES AND DISEASES , 47 (3) pp. 166-175. 10.1016/j.bcmd.2011.07.002.

Mansour, MR; Look, AT; (2011) Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma. CANCER CELL , 20 (5) pp. 559-561. 10.1016/j.ccr.2011.10.027.

Maramba, A; North, J; Lowdell, MW; Donaldson, C; (2011) IgM ligation triggers Zeta associated protein of 70 kDa (ZAP-70) tyrosine 292 and 319 phosphorylation in B-Chronic lymphocytic leukaemia (B-CLL). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 72-73). WILEY-BLACKWELL

Marks, R; Rizzi, M; Neumann, C; Fielding, A; Goldacker, S; Salzer, U; Eibel, H; ... Peter, H; + view all (2011) Allogeneic stem cell transplantation in patients with common variable immunodeficiency. In: BONE MARROW TRANSPLANTATION. (pp. S163 - S163). NATURE PUBLISHING GROUP

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update April 2011. TISSUE ANTIGENS , 78 (4) pp. 299-306. 10.1111/j.1399-0039.2011.01758.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2010. TISSUE ANTIGENS , 77 (2) pp. 167-175. 10.1111/j.1399-0039.2010.01595.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2011. TISSUE ANTIGENS , 78 (6) pp. 474-481. 10.1111/j.1399-0039.2011.01792.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update December 2010. TISSUE ANTIGENS , 77 (4) pp. 362-363. 10.1111/j.1399-0039.2011.01642.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update February 2011. TISSUE ANTIGENS , 77 (6) pp. 613-617. 10.1111/j.1399-0039.2011.01688.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update January 2011. TISSUE ANTIGENS , 77 (6) pp. 603-612. 10.1111/j.1399-0039.2011.01687.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2010. TISSUE ANTIGENS , 77 (2) pp. 162-166. 10.1111/j.1399-0039.2010.01594.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2011. TISSUE ANTIGENS , 78 (6) pp. 468-473. 10.1111/j.1399-0039.2011.01790.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update June 2011. TISSUE ANTIGENS , 78 (4) pp. 314-319. 10.1111/j.1399-0039.2011.01760.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update March 2011. TISSUE ANTIGENS , 78 (1) pp. 77-79. 10.1111/j.1399-0039.2011.01696.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update May 2011. TISSUE ANTIGENS , 78 (4) pp. 307-313. 10.1111/j.1399-0039.2011.01759.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update November 2010. TISSUE ANTIGENS , 77 (4) pp. 355-361. 10.1111/j.1399-0039.2011.01643.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update October 2010. TISSUE ANTIGENS , 77 (4) pp. 349-354. 10.1111/j.1399-0039.2011.01644.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update September 2010. TISSUE ANTIGENS , 77 (3) pp. 268-270. 10.1111/j.1399-0039.2010.01604.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update September 2011. TISSUE ANTIGENS , 78 (6) pp. 482-484. 10.1111/j.1399-0039.2011.01797.x.

Martins, I; Kepp, O; Schlemmer, F; Adjemian, S; Tailler, M; Shen, S; Michaud, M; ... Kroemer, G; + view all (2011) Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene , 30 (10) pp. 1147-1158. 10.1038/onc.2010.500.

Mattar, CNZ; Nathwani, AC; Waddington, SN; Dighe, N; Kaeppel, C; Nowrouzi, A; Mcintosh, J; ... Chan, JKY; + view all (2011) Stable Human FIX Expression After 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-associated Viral Vector 5 and 8 in Macaques. MOL THER , 19 (11) 1950 - 1960. 10.1038/mt.2011.107.

Mattes, FM; Vargas, A; Kopycinski, J; Hainsworth, EG; Sweny, P; Nebbia, G; Bazeos, A; ... Emery, VC; + view all (2011) Erratum: Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation (American Journal of Transplantation (2008) 8 (990-999) DOI: 10.1111/j.1600-6143.2008.02191.x). American Journal of Transplantation , 11 (5) 1107-. 10.1111/j.1600-6143.2011.03549.x.

Mattes, FM; Vargas, A; Kopycinski, J; Hainsworth, EG; Sweny, P; Nebbia, G; Bazeos, A; ... Klenerman, P; + view all (2011) Functional Impairment of Cytomegalovirus Specific CD8 T Cells Predicts High-Level Replication After Renal Transplantation. American Journal of Transplantation (vol 8, pg 990, 2008). WILEY-BLACKWELL

Mavroudis, C; Majumder, B; Lowdell, M; Rakhit, R; (2011) Platelet Monocyte Aggregates Correlate with Indices of Microvascular Dysfunction (Coronary Wedge Pressure and Index of Microvascular Resistance) During PCI for Stable Angina and Non-ST Segment Elevation Acute Coronary Syndrome. In: LIPPINCOTT WILLIAMS & WILKINS

McDonald, V; Machin, SJ; Mackie, IJ; Scully, MA; (2011) The Prognostic Effects of Anti-ADAMTS13 IgG, IgA and IgM Antibody Subclasses In Acute Idiopathic TTP and the Effect of Rituximab. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1421). AMER SOC HEMATOLOGY

McDonald, V; Pizzey, A; Machin, SJ; Scully, MA; (2011) The development of acute idiopathic TTP is not associated with changes in T cell or T-regulatory cell numbers. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 915-916.

McIntosh, J; Lenting, P; Tuddenham, E; Nawathe, S; Waddington, S; Gray, J; Davidoff, A; (2011) AAV mediated Factor VIII expression from a novel expression cassette with a potent codon-optimised FVIII construct. HUMAN GENE THERAPY , 22 (10) A28 - A28.

McIntosh, JH; Cochrane, M; Cobbold, S; Waldmann, H; Nathwani, SA; Davidoff, AM; Nathwani, AC; (2011) Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine. Gene Ther. 10.1038/gt.2011.64.

Michaud, M; Martins, I; Sukkurwala, AQ; Adjemian, S; Ma, Y; Pellegatti, P; Shen, S; ... Kroemer, G; + view all (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science , 334 (6062) pp. 1573-1577. 10.1126/science.1208347.

Mingozzi, F; Basner-Tschakarjan, E; Chen, Y; Nathwani, AC; Tuddenham, EGD; Rosales, C; McIntosh, J; ... High, KA; + view all (2011) Dose-dependent activation of capsid-specific T cells after AAV serotype 8 vector administration in a clinical study for hemophilia B. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 761-762.

Mitchison, NA; Bhattacharya, S; Tuddenham, EGD; (2011) Human Congenital Diseases with Mixed Modes of Inheritance Have a Shortage of Recessive Disease. A Demographic Scenario? ANN HUM GENET , 75 688 - 693. 10.1111/j.1469-1809.2011.00679.x.

Mohamedbhai, SG; Sibson, K; Marafioti, T; Kayani, I; Lowry, L; Goldstone, AH; Linch, DC; (2011) Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index > 95%. BRIT J HAEMATOL , 152 (2) 175 - 181. 10.1111/j.1365-2141.2010.08447.x.

Mohammed, K; Dignan, F; Ethell, ME; Davies, FE; Morgan, GJ; Riley, U; Evans, S; ... Shaw, BE; + view all (2011) An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. LEUKEMIA LYMPHOMA , 52 (2) 339 - 340. 10.3109/10428194.2010.527407.

Moore, S; Peggs, K; Thomson, K; Ljubic, A; Goldstone, AH; Linch, DC; Ardeshna, K; (2011) AUTOLOGOUS STEM CELL TRANSPLANTATION REMAINS BENEFICIAL FOR PATIENTS RELAPSING AFTER R-CHOP AND WHO RESPOND TO SALVAGE CHEMOTHERAPY. In: ANNALS OF ONCOLOGY. (pp. 107 - 107). OXFORD UNIV PRESS

Morris, CR; Kim, HY; Trachtenberg, F; Wood, J; Quinn, CT; Sweeters, N; Kwiatkowski, JL; ... Thalassemia Clinical Res Network, ; + view all (2011) Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. BLOOD , 118 (14) 3794 - 3802. 10.1182/blood-2010-11-319152.

N

Nathwani, A; Tuddenham, EGD; Rosales, C; Macintosh, J; Chowdary, P; Riddell, A; Aghighi, S; ... Davidoff, AM; + view all (2011) A Phase I/II clinical trial entailing peripheral vein administration of a novel self complementary adeno-associated viral vector encoding human FIX for Haemophilia B gene therapy. HUMAN GENE THERAPY , 22 (10) A20 - A20.

Nathwani, AC; Rosales, C; McIntosh, J; Rastegarlari, G; Nathwani, D; Raj, D; Nawathe, S; ... Davidoff, AM; + view all (2011) Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins. MOL THER , 19 (5) 876 - 885. 10.1038/mt.2010.274.

Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, J; Linch, DC; Chowdary, P; ... Davidoff, AM; + view all (2011) Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B. NEW ENGLAND JOURNAL OF MEDICINE , 365 (25) pp. 2357-2365. 10.1056/NEJMoa1108046.

Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, JH; Linch, DC; Chowdary, P; ... Davidoff, A; + view all (2011) Adeno-Associated Viral Vector Mediated Gene Transfer for Hemophilia B. BLOOD , 118 (21) pp. 4-5.

Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, JH; Linch, DC; Chowdary, P; ... Davidoff, A; + view all (2011) Adeno-Associated Viral Vector Mediated Gene Transfer for Hemophilia B. In: (pp. pp. 4-5).

Nathwani, AC; Tuddenham, EGD; Rosales, C; Macintosh, J; Chowdary, P; Riddell, A; Aghighi, S; ... Davidoff, AM; + view all (2011) A phase i/ii clinical trial entailing peripheral vein administration of a novel self complementary adeno-associated viral vector encoding human fix for haemophilia b gene therapy. In: HUMAN GENE THERAPY. (pp. A7 - A8). MARY ANN LIEBERT INC

Neufeld, EJ; Galanello, R; Viprakasit, V; Aydinok, Y; Piga, A; Harmatz, P; Forni, GL; ... Rienhoff, HY; + view all (2011) Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 315-316). AMER SOC HEMATOLOGY

Nolte, F; Angelucci, E; Beris, P; Macwhannell, A; Selleslag, D; Schumann, C; Xicoy, B; ... Hofmann, W-K; + view all (2011) Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox. Leuk Res , 35 (9) pp. 1131-1135. 10.1016/j.leukres.2011.06.013.

O

O'Mahony, C; Coats, C; Cardona, M; Garcia, A; Calcagnino, M; Murphy, E; Lachmann, R; ... Elliott, PM; + view all (2011) Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. EUROPACE , 13 (12) pp. 1781-1788. 10.1093/europace/eur267.

O’Connell, N.M.; (2011) Factor XI Deficiency: a study of clinical, laboratory and molecular modifiers of bleeding phenotype. Doctoral thesis , UCL (University College London). Green open access
file

P

Pascual-Garcia, M; Carbo, JM; Leon, T; Matalonga, J; Out, R; Van Berkel, T; Sarrias, M-R; ... Valledor, AF; + view all (2011) Liver X Receptors Inhibit Macrophage Proliferation through Downregulation of Cyclins D1 and B1 and Cyclin-Dependent Kinases 2 and 4. JOURNAL OF IMMUNOLOGY , 186 (8) pp. 4656-4667. 10.4049/jimmunol.1000585.

Patel, B; Dey, A; Ghorani, E; Kumar, S; Malam, Y; Rai, L; Steele, AJ; ... Fielding, AK; + view all (2011) Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights. MOL THER , 19 (6) 1034 - 1040. 10.1038/mt.2011.44.

Pavlova, EV; Deegan, PB; Tindall, J; McFarlane, I; Mehta, A; Hughes, D; Wraith, JE; (2011) Potential biomarkers of osteonecrosis in Gaucher disease. BLOOD CELLS MOLECULES AND DISEASES , 46 (1) pp. 27-33. 10.1016/j.bcmd.2010.10.010.

Payne, EM; Bolli, N; Rhodes, J; Abdel-Wahab, OI; Levine, R; Hedvat, CV; Stone, R; ... Look, AT; + view all (2011) Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. BLOOD , 118 (4) pp. 903-915. 10.1182/blood-2010-11-318022.

Peggs, K; (2011) The role of alemtuzumab in allogeneic stem cell transplantation. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 19). WILEY-BLACKWELL

Peggs, KS; (2011) Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignancies. EXPERT REVIEW OF ANTICANCER THERAPY , 11 (11) pp. 1667-1670. 10.1586/ERA.11.159.

Peggs, KS; Kayani, I; Edwards, N; Kottaridis, P; Goldstone, AH; Linch, DC; Hough, R; ... Mackinnon, S; + view all (2011) Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell-Depleted Allogeneic Transplantation for Hodgkin's Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , 29 (8) 971 - 978. 10.1200/JCO.2010.32.1711.

Peggs, KS; Kayani, I; Thomson, K; Morris, E; Kottaridis, P; Ardeshna, KM; Fielding, A; ... Mackinnon, S; + view all (2011) Positive Pre-Transplantation ([18-F]) FDG-PET Is Not a Barrier to Successful Allograft Outcomes in Chemosensitive Hodgkin Lymphoma. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 881). AMER SOC HEMATOLOGY

Peggs, KS; Thomson, K; Samuel, E; Dyer, G; Armoogum, J; Chakraverty, R; Pang, K; ... Lowdell, MW; + view all (2011) Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation. CLIN INFECT DIS , 52 (1) 49 - 57. 10.1093/cid/ciq042.

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; ... Taher, A; + view all (2011) Continued improvement in myocardial T2(star) over two years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload. Haematologica - The Hematology Journal , 96 (1) 48 - 54. 10.3324/haematol.2010.031468. Green open access
file

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; ... Taher, A; + view all (2011) Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload. Haematologica , 96 (1) pp. 48-54. 10.3324/haematol.2010.031468.

Perera, G; Ainali, C; Barinaga, G; Williams, A; Mirza, M; Kassen, D; Barker, J; ... Nestle, F; + view all (2011) Systems analysis of psoriasis reveals a dominant IL-22 signature and IL-22 as non redundant checkpoint in psoriatic inflammation. In: JOURNAL OF INVESTIGATIVE DERMATOLOGY. (pp. S89 - S89). NATURE PUBLISHING GROUP

Perera, GK; Williams, A; Barinaga, G; Kassen, D; Barker, J; Ouyang, W; Nestle, FO; (2011) IL-22 is a potential therapeutic target in psoriasis. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 905 - 906). WILEY-BLACKWELL

Pfeifer, H; Cazzaniga, G; Spinelli, O; Cayuela, J-M; Cave, H; Vandenberghe, P; Chillon, C; ... Ottmann, OG; + view all (2011) International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). (pp. p. 1087). AMER SOC HEMATOLOGY

Popat, R; Dickson, J; Khan, I; Cheesman, S; Percy, L; Moore, S; D'Sa, S; ... Yong, K; + view all (2011) An Alternate Day Dosing Strategy for Lenalidomide in Multiple Myeloma Improves Cost-Effectiveness Whilst Maintaining Efficacy. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1797). AMER SOC HEMATOLOGY

Porakishvili, N; Memon, A; Vispute, K; Kulikova, N; Clark, EA; Rai, KR; Nathwani, A; ... Lydyard, PM; + view all (2011) CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells. BRIT J HAEMATOL , 153 (4) 486 - 498. 10.1111/j.1365-2141.2011.08605.x.

Porter, JB; Evangeli, M; El-Beshlawy, A; (2011) The challenges of adherence and persistence with iron chelation therapy. INTERNATIONAL JOURNAL OF HEMATOLOGY , 94 (5) pp. 453-460. 10.1007/s12185-011-0927-3.

Porter, JB; Lin, KH; Beris, P; Forni, GL; Taher, A; Habr, D; Domokos, G; ... EPIC Study Investigators, ; + view all (2011) Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias. EUR J HAEMATOL , 87 (4) 338 - 348. 10.1111/j.1600-0609.2011.01660.x. Gold open access

Pospori, C; Xue, SA; Holler, A; Voisine, C; Perro, M; King, J; Fallah-Arani, F; ... Morris, EC; + view all (2011) Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination. BLOOD , 117 (25) 6813 - 6824. 10.1182/blood-2010-08-304568.

Q

Quezada, SA; Peggs, KS; (2011) Tumor-reactive CD4(+) T cells: plasticity beyond helper and regulatory activities. IMMUNOTHERAPY-UK , 3 (8) 915 - 917. 10.2217/IMT.11.83.

Quezada, SA; Peggs, KS; Simpson, TR; Allison, JP; (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. IMMUNOL REV , 241 104 - 118. 10.1111/j.1600-065X.2011.01007.x.

R

REA, CJ; FOLEY, JH; INGERSLEV, J; SØRENSEN, B; (2011) Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A. Journal of Thrombosis and Haemostasis , 9 (3) pp. 510-516. 10.1111/j.1538-7836.2010.04171.x.

Raj, D; Davidoff, AM; Nathwani, AC; (2011) Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges. EXPERT REV HEMATOL , 4 (5) 539 - 549. 10.1586/EHM.11.48.

Raj, D; Peggs, K; Pule, M; Linch, D; Davies, M; Nathwani, A; (2011) Adoptive immunotherapy for patients with chronic lymphocytic leukaemia using a chimeric antigen receptor targeting CD23. In: HUMAN GENE THERAPY. (pp. A120 - A121). MARY ANN LIEBERT INC

Ramus, SJ; Kartsonaki, C; Gayther, SA; Pharoah, PDP; Sinilnikova, OM; Beesley, J; Chen, XQ; ... Consortium Investigators Modifiers, ; + view all (2011) Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers. J NATL CANCER I , 103 (2) ? - ?. 10.1093/jnci/djq494.

Rienhoff, HY; Viprakasit, V; Tay, L; Harmatz, P; Vichinsky, E; Chirnomas, D; Kwiatkowski, JL; ... Neufeld, EJ; + view all (2011) A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 96 (4) pp. 521-525. 10.3324/haematol.2010.034405.

Rizzi, M; Neumann, C; Fielding, AK; Marks, R; Goldacker, S; Thaventhiran, J; Tarzi, MD; ... Peter, H-H; + view all (2011) Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , 128 (6) 1371-U783. 10.1016/j.jaci.2011.07.055.

Robinson, J; Mistry, K; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2011) The IMGT/HLA Database. Nucleic Acids Research , 39 D1171-D1176.

Robinson, J; Mistry, K; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2011) The IMGT/HLA database. NUCLEIC ACIDS RESEARCH , 39 D1171-D1176. 10.1093/nar/gkq998.

Robinson, SP; Luan, J; Canals, C; Peggs, K; Le Gouill, S; Nicolaus, K; Milpied, N; ... Schmitz, N; + view all (2011) REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA: THE EBMT EXPERIENCE. In: ANNALS OF ONCOLOGY. (pp. 94 - 95). OXFORD UNIV PRESS

Roddie, C; Peggs, KS; (2011) Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation. EXPERT OPIN BIOL TH , 11 (4) 473 - 487. 10.1517/14712598.2011.554811.

Rosales, C; McIntosh, J; Hanley, J; Nathwani, A; Morton, C; Davidoff, A; (2011) A novel epigenetic modifier significantly improves recombinant adeno-associated virus vector mediated transgene expression in mice. HUMAN GENE THERAPY , 22 (10) A107 - A107.

S

Sabry, M; Tsirogianni, M; Bakhsh, IA; North, J; Sivakumaran, J; Giannopoulos, K; Anderson, R; ... Lowdell, MW; + view all (2011) Leukemic Priming of Resting NK Cells Is Killer Ig-like Receptor Independent but Requires CD15-Mediated CD2 Ligation and Natural Cytotoxicity Receptors. JOURNAL OF IMMUNOLOGY , 187 (12) pp. 6227-6234. 10.4049/jimmunol.1101640.

Saifee, TA; Elliott, KJ; Rabin, N; Yong, KL; D'Sa, S; Brandner, S; Lunn, MP; ... Reilly, MM; + view all (2011) Bortezomib-induced inflammatory neuropathy (vol 15, pg 366, 2010). J PERIPHER NERV SYST , 16 (1) 74 - 74. 10.1111/j.1529-8027.2011.00315.x.

Scully, M; McDonald, V; Cavenagh, J; Hunt, BJ; Longair, I; Cohen, H; Machin, SJ; (2011) A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura. BLOOD , 118 (7) 1746 - 1753. 10.1182/blood-2011-03-341131.

Shah, K; Coats, C; O'Mahony, C; Cardona, M; Garcia, A; Murphy, E; Lachmann, R; ... Elliott, PM; + view all (2011) Exercise capacity predicts prognosis in anderson fabry disease. EUROPEAN HEART JOURNAL , 32 p. 273.

Shaw, BE; Apperley, JF; Russell, NH; Craddock, C; Liakopoulou, E; Potter, MN; Wynn, R; ... Byrne, JL; + view all (2011) Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. BRIT J HAEMATOL , 153 (2) 244 - 252. 10.1111/j.1365-2141.2011.08615.x.

Shaw, BE; Confer, DL; Hwang, WY; Pamphilon, DH; Pulsipher, MA; (2011) Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association. HAEMATOL-HEMATOL J , 96 (7) 942 - 947. 10.3324/haematol.2011.045740. Gold open access

Shiltagh, N; Hansen, FD; Gomez, K; Perkins, SJ; Tuddenham, EGD; (2011) Reassignment of the modular architecture of von Willebrand factor: novel structural insights into the non-a repeat region revealing the major FVIII binding region. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 661-662.

Smith, GC; Alpendurada, F; Carpenter, JP; Alam, MH; Berdoukas, V; Karagiorga, M; Ladis, V; ... Pennell, DJ; + view all (2011) Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE , 13 (ARTN 34) 10.1186/1532-429X-13-34.

Sobota, A; Yamashita, R; Xu, Y; Trachtenberg, F; Kohlbry, P; Kleinert, DA; Giardina, PJ; ... Thalassemia Clinical Res Network, ; + view all (2011) Quality of life in Thalassemia: A comparison of SF-36 results from the Thalassemia longitudinal cohort to reported literature and the US norms. AM J HEMATOL , 86 (1) 92 - 95. 10.1002/ajh.21896.

Starke, RD; Ferraro, F; Paschalaki, KE; Dryden, NH; McKinnon, TAJ; Sutton, RE; Payne, EM; ... Randi, AM; + view all (2011) Endothelial von Willebrand factor regulates angiogenesis. BLOOD , 117 (3) 1071 - 1080. 10.1182/blood-2010-01-264507.

Starke, RD; Paschalaki, KE; Ferraro, F; Dryden, NH; McKinnon, TAJ; Sutton, RE; Payne, EM; ... Randi, AM; + view all (2011) BLOOD-DERIVED ENDOTHELIAL PROGENITOR CELLS FROM VON WILLEBRAND'S DISEASE PATIENTS DEMONSTRATE THAT VON WILLEBRAND FACTOR REGULATES ANGIOGENESIS. HEART , 97 (20) 14 - 14. 10.1136/heartjnl-2011-300920b.39.

Steele, AJ; Prentice, AG; Last, V; Hoffbrand, AV; Wickremasinghe, RG; (2011) The p90RSK Inhibitor BI-D1870 Induces Apoptosis in CLL Cells. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1067). AMER SOC HEMATOLOGY

Swerdlow, AJ; Higgins, CD; Smith, P; Cunningham, D; Hancock, BW; Horwich, A; Hoskin, PJ; ... Linch, DC; + view all (2011) Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study. JOURNAL OF CLINICAL ONCOLOGY , 29 (31) pp. 4096-4104. 10.1200/JCO.2011.34.8268.

T

Taher, AT; Porter, JB; Viprakasit, V; Kattamis, A; Chuncharunee, S; Sutcharitchan, P; Siritanaratkul, N; ... Cappellini, MD; + view all (2011) Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 412-413). AMER SOC HEMATOLOGY

Taner, SB; Pando, MJ; Roberts, A; Schellekens, J; Marsh, SGE; Malmberg, K-J; Parham, P; (2011) Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. J Immunol , 186 (1) pp. 62-72. 10.4049/jimmunol.0903657.

Tat, PA; Sumer, H; Pralong, D; Verma, PJ; (2011) The Efficiency of Cell Fusion-Based Reprogramming Is Affected by the Somatic Cell Type and the Age of Somatic Cells. Cellular Reprogramming (Formerly "Cloning and Stem Cells") , 13 (4) pp. 331-344. 10.1089/cell.2011.0002.

Tavarozzi, F; Mayor, NP; Cooke, L; Madrigal, JA; Marsh, SGE; Shaw, BE; (2011) Impact of HLA-DPA1 matching status on outcome, following unrelated donor hematopoietic stem cell transplantation, in the context of a 10/10 HLA-matched background. In: TISSUE ANTIGENS. (pp. 381 - 381). WILEY-BLACKWELL

Taveirne, S; De Colvenaer, V; Van Den Broeck, T; Van Ammel, E; Bennett, CL; Taghon, T; Vandekerckhove, B; ... Leclercq, G; + view all (2011) Langerhans cells are not required for epidermal V gamma 3 T cell homeostasis and function. Journal of Leukocyte Biology , 90 (1) 61 - 68. 10.1189/jlb.1010581.

Thephinlap, C; Phisalaphong, C; Lailerd, N; Chattipakorn, N; Winichagoon, P; Vadolus, J; Fucharoen, S; ... Srichairatanakool, S; + view all (2011) Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids. MED CHEM , 7 (1) 62 - 69.

Thomas, MR; Machin, SJ; Mackie, I; Scully, MA; (2011) B cell activating factor is elevated in acute idiopathic thrombotic thrombocytopenic purpura. BRITISH JOURNAL OF HAEMATOLOGY , 155 (5) pp. 620-622. 10.1111/j.1365-2141.2011.08730.x.

Thomas, MR; Machin, SJ; Mackie, I; Scully, MA; (2011) B cell-activating factor (BAFF) is elevated in acute idiopathic thrombotic thrombocytopenic purpura (TTP). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 8). WILEY-BLACKWELL

Thomson, KJ; Mackinnon, S; (2011) T-Cell-Depleted Reduced-Intensity Conditioning Transplantation for Lymphoma: Do Donor Lymphocyte Infusions Really Matter? Reply. J CLIN ONCOL , 29 (9) E244 - E244. 10.1200/JCO.2010.33.1207.

Torralba-Cabeza, M-A; Olivera, S; Hughes, DA; Pastores, GM; Nuviala Mateo, R; Perez-Calvo, J-I; (2011) Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease. MOLECULAR GENETICS AND METABOLISM , 104 (3) pp. 301-307. 10.1016/j.ymgme.2011.06.021.

Townsend, W; Holroyd, A; Pearce, RM; Mackinnon, S; Goldstone, AH; Linch, DC; Peggs, KS; ... Morris, E; + view all (2011) A Simple Prognostic Score to Predict Short and Long-Term Survival Following ICU Admission in Critically III Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: Improved Survival Following Reduced Intensity Conditioning. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 70-71). AMER SOC HEMATOLOGY

Trachtenberg, F; Vichinsky, E; Haines, D; Pakbaz, Z; Mednick, L; Sobota, A; Kwiatkowski, J; ... Thalassemia Clinical Res Network, ; + view all (2011) Iron Chelation Adherence to Deferoxamine and Deferasirox in Thalassemia. AM J HEMATOL , 86 (5) 433 - 436. 10.1002/ajh.21993.

Tsui, NBY; Kadir, RA; Chan, KCA; Chi, C; Mellars, G; Tuddenham, EG; Leung, TY; ... Lo, YMD; + view all (2011) Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. BLOOD , 117 (13) pp. 3684-3691. 10.1182/blood-2010-10-310789.

Tulpule, S; Russell, NH; Byrne, J; Das-Gupta, EP; Ethell, ME; Figueroa, D; Madrigal, JA; ... Shaw, BE; + view all (2011) High Absolute T Regulatory Cell Counts and Resistance of CD8 Central Memory Cells to Killing by Fludarabine Predicts for Poor Responses to DLI in the Context of a Pre-DLI Lymphoreduction, Strategy. In: (pp. p. 834).

V

Velica, P; Bunce, CM; (2011) A QUICK, SIMPLE AND UNBIASED METHOD TO QUANTIFY C2C12 MYOGENIC DIFFERENTIATION. MUSCLE NERVE , 44 (3) 366 - 370. 10.1002/mus.22056.

Vichinsky, E; Bernaudin, F; Forni, GL; Gardner, R; Hassell, K; Heeney, MM; Inusa, B; ... Coates, T; + view all (2011) Long-term safety and efficacy of deferasirox (Exjade (R)) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. BRIT J HAEMATOL , 154 (3) 387 - 397. 10.1111/j.1365-2141.2011.08720.x.

Vichinsky, EP; Ohene-Frempong, K; (2011) Approaches to Transfusion Therapy and Iron Overload in Patients with Sickle Cell Disease: Results of an International Survey. PEDIATRIC HEMATOLOGY AND ONCOLOGY , 28 (1) pp. 37-42. 10.3109/08880018.2010.505497.

Vichinsky, EP; Ohene-Frempong, K; Thein, SL; Lobo, CLD; Inati, A; Thompson, AA; Smith-Whitley, K; ... Marks, PW; + view all (2011) Transfusion and Chelation Practices in Sickle Cell Disease: A Regional Perspective. PEDIATR HEMAT ONCOL , 28 (2) 124 - 133. 10.3109/08880018.2010.505506.

Violi, F; Basili, S; Raparelli, V; Chowdary, P; Gatt, A; Burroughs, AK; (2011) Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? JOURNAL OF HEPATOLOGY , 55 (6) pp. 1415-1427. 10.1016/j.jhep.2011.06.008.

Virgilio, M; Payne, E; Narla, A; Sun, H; Paw, BH; Look, T; Ebert, BL; ... Khanna-Gupta, A; + view all (2011) L-Leucine Improves the Anemia of the 5q-Syndrome Via Activation of the mTOR (mammalian target of rapamycin) Pathway. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 443-444). AMER SOC HEMATOLOGY

van der Pol, E; Gardiner, C; Harrison, P; Grootemaat, AE; Sturk, A; van Leeuwen, TG; Nieuwland, R; (2011) Size distribution and concentration of microparticles and exosomes determined by advanced optical and non-optical detection methods. In: (pp. p. 184). WILEY-BLACKWELL

W

Ward, NJ; Buckley, SMK; Waddington, SN; VandenDriessche, T; Chuah, MKL; Nathwani, AC; McIntosh, J; ... McVey, JH; + view all (2011) Codon optimization of human factor VIII cDNAs leads to high-level expression. BLOOD , 117 (3) 798 - 807. 10.1182/blood-2010-05-282707.

Wechalekar, AD; Dubrey, SW; Comenzo, RL; (2011) Amyloidosis. In: Myeloma: Pathology, Diagnosis, and Treatment. (pp. 174-189).

Weinreb, N; Belmatoug, N; Bembi, B; Bodamer, O; Cappellini, MD; Deegan, PB; Elstein, D; ... Therapeutic Goals MAP Taskforce, ; + view all (2011) A novel tool for mapping disease severity and outcomes in patients with Gaucher disease utilising the therapeutic goals. In: MOLECULAR GENETICS AND METABOLISM. (pp. S46 - S46). ACADEMIC PRESS INC ELSEVIER SCIENCE

Wickremasinghe, RG; Prentice, AG; Steele, AJ; (2011) Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets. BRIT J HAEMATOL , 153 (5) 545 - 556. 10.1111/j.1365-2141.2011.08676.x.

Wickremasinghe, RG; Prentice, AG; Steele, AJ; (2011) p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. LEUKEMIA , 25 (9) 1400 - 1407. 10.1038/leu.2011.103.

Wiener, E; Rafique, R; Pizzey, A; Adejumo, T; Chennell, G; Porter, JB; (2011) Upregulation of Hepatocellular NTBI Clearance Following Iron Loading Is Associated with Modulation of Membrane T- and L-Type Calcium Channels. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 479). AMER SOC HEMATOLOGY

Y

Yan, R; El-Emir, E; Rajkumar, V; Robson, M; Jathoul, AP; Pedley, RB; Arstad, E; (2011) One-Pot Synthesis of an I-125-Labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. ANGEW CHEM INT EDIT , 50 (30) 6793 - 6795. 10.1002/anie.201102072.

This list was generated on Sun Aug 18 05:04:56 2019 BST.